Base
English Name

Robert E. Burrier

Deparment

Manager

Research Fields of Interest

Consultant to Biocon, Chief Operating Officer and Vice-President Of Research and Development, Stemina Biomarker Discovery
A career technology executive with deep experience in pharmaceutical research, ‘biosupplier’ product development, and biotech services, Dr. Burrier brings over 25 years of drug discovery, assay development, as well as project and business leadership experience to Biocon.

While working in pharma, he participated and led programs resulting in drugs currently on the market including Zetia, Vytorin, and others. He has expertise in assays and paradigms used for drug discovery having participated in over 150 drug discovery programs while working for Schering-Plough, Eli Lilly, GelTex and Genzyme in the areas of cell biology, cell media development, assay development. In the biosupplier arena, Dr. Burrier led teams to innovate on workflow improvements with companies including Invitrogen, and EMD Millipore (Merck).  Dr. Burrier received his PhD in biochemistry from Boston University and was a Fellow at both Wake Forest University and Boston University.